申请人:THE KITASATO INSTITUE
公开号:US20150344404A1
公开(公告)日:2015-12-03
The present invention to provide a novel pyruvate dehydrogenase kinase inhibitors. A pyruvate dehydrogenase kinase inhibitor comprising a compound represented by the general formula (I) as an active ingredient (wherein, ring A represents a 6-membered aromatic hydrocarbon ring optionally substituted with 2-4 substituents,
R
1
and R
4
, which are the same or different, represent a hydrogen atom, a hydroxyl group, an optionally substituted C1-6 alkyl group, R
2
and R
3
, which are the same or different, represent a hydrogen atom, a carboxyl group, an optionally substituted C1-6 alkyl group, an optionally substituted C6-10 aryl group, or a group represented by —C (═R
9
)—R
10
), a pharmaceutical composition for treatment or prophylaxis of diseases or disorders that pyruvate dehydrogenase kinase relates to its development or aggravation, and a cosmetic composition, and the like.
本发明提供了一种新型丙酮酸脱氢酶激酶抑制剂。一种丙酮酸脱氢酶激酶抑制剂包括一种以通式(I)表示的化合物作为活性成分(其中,环A代表一个6-成员芳香碳氢环,可选择地取代有2-4个取代基,R1和R4,它们相同或不同,代表氢原子,羟基,可选择地取代的C1-6烷基基团,R2和R3,它们相同或不同,代表氢原子,羧基,可选择地取代的C1-6烷基基团,可选择地取代的C6-10芳基基团,或由—C(═R9)—R10表示的基团),一种用于治疗或预防与丙酮酸脱氢酶激酶有关的疾病或紊乱的药物组合物,以及一种化妆品组合物等。